Cargando…

Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’

Detalles Bibliográficos
Autores principales: Shiti, Assad, Goldfracht, Idit, Shaheen, Naim, Protze, Stephanie, Gepstein, Lior
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979785/
https://www.ncbi.nlm.nih.gov/pubmed/33741922
http://dx.doi.org/10.1038/s41467-021-21950-6
_version_ 1783667336844148736
author Shiti, Assad
Goldfracht, Idit
Shaheen, Naim
Protze, Stephanie
Gepstein, Lior
author_facet Shiti, Assad
Goldfracht, Idit
Shaheen, Naim
Protze, Stephanie
Gepstein, Lior
author_sort Shiti, Assad
collection PubMed
description
format Online
Article
Text
id pubmed-7979785
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79797852021-04-16 Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’ Shiti, Assad Goldfracht, Idit Shaheen, Naim Protze, Stephanie Gepstein, Lior Nat Commun Matters Arising Nature Publishing Group UK 2021-03-19 /pmc/articles/PMC7979785/ /pubmed/33741922 http://dx.doi.org/10.1038/s41467-021-21950-6 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Matters Arising
Shiti, Assad
Goldfracht, Idit
Shaheen, Naim
Protze, Stephanie
Gepstein, Lior
Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_full Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_fullStr Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_full_unstemmed Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_short Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
title_sort reply to ‘are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
topic Matters Arising
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979785/
https://www.ncbi.nlm.nih.gov/pubmed/33741922
http://dx.doi.org/10.1038/s41467-021-21950-6
work_keys_str_mv AT shitiassad replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation
AT goldfrachtidit replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation
AT shaheennaim replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation
AT protzestephanie replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation
AT gepsteinlior replytoareatrialhumanpluripotentstemcellderivedcardiomyocytesreadytoidentifydrugsthatbeatatrialfibrillation